Table of Contents
Conference Papers in Medicine
Volume 2013 (2013), Article ID 729850, 3 pages
Conference Paper

New Aspects on Arterial Hypertension

Department of General and Interventional Cardiology, Hamburg University Heart Center, 20246 Hamburg, Germany

Received 15 January 2013; Accepted 1 April 2013

Academic Editors: A. Bellou, E. Giannitsis, C. Hamm, M. Möckel, and J. Searle

This Conference Paper is based on a presentation given by Stefan Blankenberg at “Clinical Decisions in Acute Patients: ACS–POCT–Hypertension and Biomarkers” held from 19 October 2012 to 20 October 2012 in Berlin, Germany.

Copyright © 2013 Johannes Tobias Neumann and Stefan Blankenberg. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Besideestablished diagnostic and therapeutic guidelines, several new approaches for the treatment of hypertension are emerging. Newer studies reveal the importance of individualized reference values for the treatment of high blood pressure. Several biomarkers have shown a predictive value for the development of hypertension, which in future might help to develop an individual risk score and therapeutic goals. In patients with therapy-resistant hypertension, renal denervation therapy offers a safe and effective therapeutic option. Follow-up studies reported a reduction of systolic blood pressure up to 32 mmHg after 24 months. A more invasive approach is the implantation of a baroreceptor stimulator, which as well was effective in treating high blood pressure. These new aspects on arterial hypertension are presented in this paper.